Virbac SA 

$0.000000
46
+$0.00+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

17SepExpected
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Next
12.09
12.43
12.76
13.09
Expected EPS
N/A
Actual EPS
N/A

Financials

10.42%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
2.92BRevenue
304.22MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VBACY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific. The company offers Vikaly, a cat food designed for the management of feline chronic kidney disease; Prevexto that contains imidacloprid and flumethrin, providing long-lasting parasite protection collar for dogs and cats at risk of fleas, ticks, lice, and sandflies; Zenidog/Zenifel offers a fogger, spray, and non-electric pheromone gel diffuser to soothe and reduce stress-related behaviors in dogs; Suigen Entero 3 is an inactivated vaccine aimed at preventing neonatal diarrhea in piglets caused by colibacillosis, clostridium, and rotavirus; Ursolyx soft chews formulated with ursolic acid that support muscle strength and mobility in dogs and cats; Zenifel a fogger and spray designed to reduce behaviors due to stress or undesirable behaviors in cats; Suigen PCV2 is a vaccine for porcine circovirus type 2; and Suigen Donoban is a multivalent vaccine used for the prevention of respiratory diseases in swine. It also provides a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, immunology, nutrition, petfood, and pharmaceutical products. In addition, the company serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Show more...
CEO
Mr. Paul Martingell
Employees
6442
Country
France
ISIN
US92766M1027

Listings

0 Comments

Share your thoughts

FAQ

What is Virbac SA stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Virbac SA stocks are traded under the ticker VBACY.
When is the next Virbac SA earnings date?
Virbac SA is going to release the next earnings report on September 17, 2026.
What is Virbac SA revenue for the last year?
Virbac SA revenue for the last year amounts to 2.92B USD.
What is Virbac SA net income for the last year?
VBACY net income for the last year is 304.22M USD.
How many employees does Virbac SA have?
As of June 11, 2026, the company has 6,442 employees.
In which sector is Virbac SA located?
Virbac SA operates in the Manufacturing sector.
When did Virbac SA complete a stock split?
Virbac SA has not had any recent stock splits.
Where is Virbac SA headquartered?
Virbac SA is headquartered in Carros, France.